Ms. Washington will continue to serve as Gilead’s CFO and executive vice president while the company works to find her replacement. If a replacement is found before March 1, 2020, she will serve as an adviser until the company is done reporting 2019 financial results.
Ms. Washington will join the long list of leadership departures from Gilead. The company also saw its CEO John Milligan, Chairman John Martin, R&D chief Norbert Bischofberger, CMO Andrew Cheng and Allesandro Riva, MD, its executive vice president of oncology, exit the company.
Alphabet, Google’s parent company, also announced that Ms. Washington will join its board of directors.
Read the full report here.
More articles on pharmacy:
10 hospitals seeking pharmacy leaders
Walgreens shaking up C-suite
Generic drugmakers could thrive in a recession, Moody’s says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
